Naphazoline Hydrochloride/Pheniramine Maleate

็›้…ธ่˜็”ฒๅ”‘ๅ•‰/้ฉฌๆฅ้…ธ้žๅฐผๆ‹‰ๆ•

Report date: 2024/01/11 16:28:58

Base Information

Drug NameNaphazoline Hydrochloride/Pheniramine Maleate
Drug Alias NameNaphazoline hydrochloride - pheniramine maleate mixt็›้…ธ่˜็”ฒๅ”‘ๅ•‰้ฉฌๆฅ้…ธ้žๅฐผๆ‹‰ๆ•้ฉฌๆฅ้…ธ้žๅฐผๆ‹‰ๆ•/็›้…ธ่˜็”ฒๅ”‘ๅ•‰naphazoline hydrochloride and pheniramine maleatepheniramine maleate and naphazoline hydrochloride +[12]ย 
ClassificationSmall molecules
Mechanisms of ActionAlpha adrenergic receptor agonistsHistamine H1 receptor antagonists
TargetsHistamine H1 receptorAlpha adrenergic receptor
Therapy Area/IndicationsHypersensitivityEye Diseases
Global Approved IndicationsEye Diseases
Approved Indications in ChinaEye Diseases
Original Approved Country/TerritoryUnited States
Original Approved Date1994/06/08
Country/TerritoryUnited StatesMainland China
CombinationsYes Naphazoline HydrochloridePheniramine Maleate
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesAlcon
China Registration ClassN/A

Develop Information

Active CompaniesKenvue Brands LlcSA Alcon Couvreur NVAlcon +[4]ย 
Inactive CompaniesN/A
Active IndicationsHypersensitivityEye Diseases
Inactive IndicationsN/A

Other Information

ATC CodeS01GA51
Related LinksKEGG